Loading…
Based on limited metadata with no full letter text available, the FDA issued a Warning Letter to 11-11-11 Brands on November 16, 2022, regarding drug products. Without access to the specific subject line or detailed violation information, the exact nature of the compliance issues cannot be determined from the available data. The letter falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in this metadata. To understand the particular violations and required corrective actions, the complete warning letter text would be needed.